MicroRNA-330 inhibited cell proliferation and enhanced chemosensitivity to 5-fluorouracil in colorectal cancer by directly targeting thymidylate synthase

Colorectal cancer (CRC) is the third most common cancer in males and the second most common in females, worldwide. Currently, 5-fluorouracil (5-FU)-mediated chemotherapy is the adjuvant treatment for patients with CRC following surgical resection. However, a number of patients with CRC develop 5-FU...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Weidong, Jiang, Huayong, Zhang, Fuli, Gao, Junmao, Hou, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431319/
https://www.ncbi.nlm.nih.gov/pubmed/28521444
http://dx.doi.org/10.3892/ol.2017.5895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431319/
https://www.ncbi.nlm.nih.gov/pubmed/28521444
http://dx.doi.org/10.3892/ol.2017.5895

Ejemplares similares